Drugs / Retaane
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT00569569 | Feb 2006 → Mar 2007 | age-related macular degeneration | Rudolf Foundation Clinic | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Retaane | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00569569 ↗ |
| Known as | Anecortave acetate | “20 patients who rejected intravitreal therapy were treated with Anecortave acetate (Retaane®) which was applied as a juxtascleral depot injection.” NCT00569569 ↗ |
| Route | Other | “juxtascleral depot injection” NCT00569569 ↗ |